Clin2
NCT04935567Possibly a fitNot yet recruiting

Predicting vagus nerve stimulation success in drug-resistant epilepsy

Drug Resistant Epilepsy

Part of Brain & nervous system clinical trials.

This study looks at whether a brain wave test can help predict how well vagus nerve stimulation (VNS) will work for people with epilepsy that hasn't been controlled by medication. VNS is a treatment that uses a device to send mild electrical signals to the brain to reduce seizures.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
18 years to 85 years
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have epilepsy that hasn't improved after trying at least two appropriate anti-seizure medications.
  • You and your doctor have already decided that VNS therapy is a good option for you.
  • You are willing to have a 20-minute EEG (brain wave recording) done, which includes flashing lights, deep breathing, and opening and closing your eyes.
  • You (or a family member or caregiver) can keep track of your seizures for at least 3 months before the VNS device is implanted, or you can report your seizure frequency reliably in other ways.
  • If you have very frequent seizures (several per day), you can just record the days when you have no seizures.
  • You are not planning to have brain surgery to remove the seizure focus, or you have clearly decided against it.
  • You do not have seizures that are not caused by epilepsy (psychogenic or other conditions) that are hard to tell apart from epileptic seizures.
  • You do not have a medical condition that could make seizures more frequent, and you are expected to live at least 2 more years.
  • You can attend regular visits for VNS programming and the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06334952Recruiting
Personalized brain stimulation for hard-to-treat epilepsy

This study tests a personalized, non-invasive brain stimulation method called tDCS for people with drug-resistant epilepsy that starts in one part of the brain. It aims to reduce seizures in those who cannot have surgery or have not been helped by surgery.

Bordeaux
NCT07640191Recruiting
New Nerve Stimulation Device for Hard-to-Treat Epilepsy

This study tests a new implanted device that stimulates the vagus nerve (a major nerve in your neck) to help reduce seizures in people whose epilepsy doesn't respond well to medications. The device is surgically placed under the skin and may help lower how often you have seizures.

Herston, Queensland
NCT03320304Recruiting
VNS for long-term depression that hasn’t improved with treatment

This trial studies how well and how efficiently VNS therapy works for people with long-lasting or repeated major depression that hasn’t responded to enough antidepressant treatments. It may help patients who are already receiving depression treatment but are still struggling.

Vienna
NCT06304389Recruiting
Blue light therapy for epilepsy with vagus nerve stimulation

This trial tests if blue light exposure can improve the effects of vagus nerve stimulation (VNS) in people with epilepsy that is hard to control. It also includes some healthy volunteers for comparison. The goal is to find new ways to make VNS work better.

Woluwe-Saint-Lambert
NCT06016686Recruiting· Phase 1
Recording nerve signals from the vagus nerve in awake humans

This study tests a new way to listen to the vagus nerve in awake people. It may help understand how the nerve controls body functions like heart rate and digestion.

Minneapolis, Minnesota
NCT07725601Recruiting
VNS dosing algorithm for epilepsy

This trial tests a new way to adjust the settings on a Vagus Nerve Stimulator (VNS) to better control seizures in people with epilepsy. It is for those who are already getting a VNS implanted to treat their seizures.

Augusta, Georgia

Hear when a new Drug Resistant Epilepsy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.